The Impact of Anlotinib on Brain Metastases of Non‐Small Cell Lung Cancer: Post Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)

BACKGROUND: Anlotinib has been shown to prolong progression‐free survival (PFS) and overall survival (OS) for non‐small cell lung cancer (NSCLC). Herein we sought to analyze the effect of anlotinib in managing brain metastases (BM) and its brain‐associated toxicities. METHODS: The PFS and OS of anlo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Jiang, Shunjun, Liang, Hengrui, Liu, Zhichao, Zhao, Shen, Liu, Jun, Xie, Zhanhong, Wang, Wei, Zhang, Yalei, Han, Baohui, He, Jianxing, Liang, Wenhua
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216446/
https://ncbi.nlm.nih.gov/pubmed/32077550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0838
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados